STELVIO THERAPEUTICS
Stelvio Oncology is developing a personalized approach to glioblastoma treatment. Their team has core competencies of scientific creativity, clinical excellence and professional management required to successfully commercialize novel drug therapies and precision medicine diagnostics.
STELVIO THERAPEUTICS
Industry:
Biotechnology Medical Oncology Pharmaceutical Precision Medicine
Founded:
2017-03-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.stelvio-oncology.com
Total Employee:
1+
Status:
Active
Contact:
(604) 788-1936
Technology used in webpage:
Euro IPv6 Cloudflare Hosting Cloudflare DNS
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Imbrium Therapeutics
Imbrium Therapeutics is a biopharma company that specializes in medical science, pharmacologic medicines, and oncology chemotherapeutics.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Metacrine
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
TheraCea Pharma
TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders.
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.stelvio-oncology.com
- Host name: 172.67.221.241
- IP address: 172.67.221.241
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Stelvio Therapeutics"
Stelvio Oncology Company Profile | Management and Employees …
Stelvio Oncology has developed an epigenetic signature based platform for identifying compounds that drive differentiation of cancer stem cells into benign cell types. Popular …See details»
Stelvio Oncology - PitchBook
When was Stelvio Oncology founded? Stelvio Oncology was founded in 2017. What is the size of Stelvio Oncology? Stelvio Oncology has 2 total employees. What industry is Stelvio Oncology …See details»
Stelvio Oncology, Inc.: Drug pipelines, Patents, Clinical trials
Sep 21, 2023 Explore Stelvio Oncology, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Stelvio Oncology Company Profile - Office Locations ... - Craft
Stelvio Oncology is a company that develops predictive diagnostics and therapeutics for malignant glioblastoma multiforme. It focuses on treatments that induce differentiation of tumor …See details»
Stelvio Oncology - Overview, News & Similar companies - ZoomInfo
Stelvio Oncology contact info: Phone number: (415) 525-6810 Website: www.stelvio-oncology.com What does Stelvio Oncology do? Stelvio Oncology has developed an epigenetic …See details»
We Nurture Your Life - Stelvio
• Welcome to the world of Stelvio… A promising R&D driven pharmaceutical Manufacturing organization. • In the Business of Manufacturing, Marketing and Export of formulations …See details»
Stelvio Therapeutics - Contacts, Employees, Board Members, …
Stelvio Oncology is focused on delivering precision medicine diagnostics and novel therapeutics for glioblastoma.See details»
Stelvio Therapeutics - Products, Competitors, Financials, …
Stelvio Therapeutics is a biotechnology company focused on the development of precision medicine and novel therapeutics for cancer treatment. The company specializes in using …See details»
Stelvio Oncology - Company Profile - Tracxn
Stelvio Oncology - Targeting resistance mechanisms using combination therapeutics for glioblastoma. Raised a total funding of $250K over 1 round from 1 investor. Stelvio Oncology …See details»
Stelvio Therapeutics - Funding, Financials, Valuation & Investors
May 5, 2017 Stelvio Oncology is focused on delivering precision medicine diagnostics and novel therapeutics for glioblastoma. Search Crunchbase. Start Free Trial . Chrome Extension. ...See details»
Stelvio Therapeutics | San Diego, CA, USA Startup - Gust
Stelvio is developing novel treatments for difficult to cure cancers with a machine learning and live imaging platform technology based on epigenetics. Find investment information and connect …See details»
Stelvio Therapeutics - Golden
Stelvio Therapeutics is a biotechnology company developing therapeutics for cancer. Overview Structured Data Issues Contributors Activity. Contents. stelvio-oncology.com. Is a. Company. …See details»
Stelvio Oncology: Live Imaging For a Paradigm Shift in Drug
Sep 8, 2017 Stelvio is a company with a unique approach to identifying the resistance mechanisms of cancer cells, and overcoming them with targeted therapies for the individual …See details»
Stelvio Therapeutics - VentureRadar
"Stelvio Therapeutics is developing therapies through epigenetics. We have invented a novel platform screening technology called Microscopic Imaging of Epigenetic Landscape (MIEL) …See details»
Stelvio Oncology was successfully accepted into Indie Bio ...
We are proud to announce that Stelvio Oncology was successfully accepted into Indie Bio Accelerator, the world's largest seed biotech ...See details»
Stelvio Therapeutics - Crunchbase
Stelvio Oncology is focused on delivering precision medicine diagnostics and novel therapeutics for glioblastoma. ... Companies like Stelvio Therapeutics include Avstera Therapeutics, Arctic …See details»
Summiting Italy’s Stelvio Pass for cancer research - Illumina
Sep 27, 2023 On September 2, 11 Illumina teammates embarked on a journey up the formidable Passo dello Stelvio as part of the Stelvio for Life charity event. As they cycled, walked, and …See details»
i2020 to Accelerate Stelvio Therapeutics First-in-Class Epigenetic ...
Mar 27, 2018 Stelvio Therapeutics is a biotechnology company that focuses on developing a pipeline of alternative treatments for malignant glioblastoma multiforme (GBM), the most …See details»
i2020 News — i2020
Apr 14, 2023 [www.stelvio-oncology.com] March 27, 2018. Maria Parshenkova. January 4, 2018. Maria Parshenkova. Torrey Pines Launches i2020 Accelerator for Early Therapeutics. January …See details»